In the News


FDA finds no link between incretin-based drugs, pancreatic complications

Data do not support a causal association between incretin-based drugs and pancreatitis or pancreatic cancer, concluded a review by U.S. and European regulatory agencies.

Sulfonylurea as second-line therapy appeared to lower cost in a population-based model

Sulfonylurea as second-line therapy for glycemic control in type 2 diabetes appeared to yield similar outcomes and quality-adjusted life-years but led to lower costs and longer time to insulin dependence compared with a dipeptidyl peptidase-4 inhibitor, glucagon-like peptide-1 receptor agonist, and insulin, according to a recent study.

Elderly patients most likely to land in ED, get admitted for insulin-related hypoglycemia

Elderly patients are more likely than younger patients to land in the ED and be hospitalized for insulin-related hypoglycemia and errors, a new study found.

MKSAP quiz: Nocturnal hypoglycemia in type 1 diabetes

This month's quiz asks readers to evaluate a 21-year-old man with type 1 diabetes being seen in the office for a follow-up to a recent hospitalization.

Standard blood glucose targets are lower than HbA1c goals require

A recent study determined the pre- and postprandial blood glucose levels that should be targeted to reach a specific HbA1c goal in patients with type 1 or type 2 diabetes.

Review: In type 1 or type 2 diabetes, group medical visits improve HbA1c levels compared with usual care

A meta-analysis of 13 randomized, controlled trials of adults with type 1 or type 2 diabetes found that group medical visits improved HbA1c levels but not the other factors studied, which included blood pressure, body mass index, weight, cholesterol, triglycerides, and quality of life.

New drug approved, meters recalled

Dapaglifozin (Farxiga), a new medication to treat type 2 diabetes, was recently approved by the FDA for use along with diet and exercise.

Spotlight on stroke risk

The effect of hyperglycemia on stroke risk was examined by several studies published in the past month.